US$ 25.78
glp-1 dexcom Benefits of using CGM with drugs for diabetes treatment with alerts and historical trends Dexcom G6 Continuous Glucose Monitor
Description
doi: 10.1111/dom.14710

This approval is important because it demonstrates what legitimate needle-free GLP-1 therapy requires

doi:10.1111/j.1463-1326.2010.01259.x 141
In murine pancreatic Min6-K8 cells, prevention of cytosolic glutamate production by KO of a key component of the malate-aspartate shuttle or triple KO of the vesicular glutamate transporters Slc17a6, Slc17a7, and Slc17a8 impaired GLP-1-induced insulin secretion [515]
